Immediate Impact
92 standout
Citing Papers
Stroke
2024 Standout
Forecasting the Burden of Cardiovascular Disease and Stroke in the United States Through 2050—Prevalence of Risk Factors and Disease: A Presidential Advisory From the American Heart Association
2024 Standout
Works of Jay Ariyawansa being referenced
Rivaroxaban reversal with prothrombin complex concentrate or tranexamic acid in healthy volunteers
2017
Pharmacokinetics, Pharmacodynamics, and Safety of Single-Dose Rivaroxaban in Chronic Hemodialysis
2016
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Jay Ariyawansa | 207 | 52 | 21 | 134 | 20 | 355 | |
| Stuart Abramson | 157 | 54 | 4 | 96 | 11 | 382 | |
| David Parra | 155 | 75 | 11 | 54 | 24 | 312 | |
| D Fitzgerald | 241 | 108 | 17 | 89 | 16 | 400 | |
| C. Kreilick | 231 | 27 | 4 | 66 | 15 | 339 | |
| Susan E. Fugate | 87 | 51 | 2 | 47 | 16 | 385 | |
| Carla B. Frye | 202 | 123 | 41 | 67 | 17 | 331 | |
| Eva‐Maria Fronk | 129 | 50 | 133 | 18 | 383 | ||
| Sigrid Narum | 55 | 90 | 6 | 21 | 19 | 365 | |
| Nicholas B. Norgard | 209 | 89 | 49 | 31 | 394 | ||
| RA Harrington | 92 | 188 | 28 | 25 | 20 | 383 |
All Works
Loading papers...